Effects of a novel hydrogel on equine bone healing: A pilot study

Summary

Objective: To examine the efficacy and biocompatibility of a thiolated gelatin-thiolated carboxymethyl hyaluronan (CMHA-SGX) sponge as an osteoconductive device in an equine second and fourth metacarpal bone defect model.

Methods: Seven millimetre segmental ostectomies were created bilaterally in the second and fourth metacarpal bones of four horses. The left and right metacarpal defects were randomly assigned to (1) be filled with a CMHA-SGX sponge (treated) or (2) were left unfilled (control). The duration of the study was nine weeks. Bone healing was evaluated using serial radiology, as well as histologically and histomorphometrically. Data were analyzed using an analysis of variance (ANOVA). The level of significance was p <0.05.

Results: Serial radiographic evaluation revealed improved healing in the treated compared to the control defects at weeks eight and nine (p = 0.02). This finding was not corroborated histologically. Histomorphometry did not reveal any significant differences in healing between experimental groups. The CMHA-SGX sponge did not inhibit bone formation, induce local inflammation or lead to surgical site infection.

Clinical significance: While further optimization to improve osteoconductive properties should be considered, the CMHA-SGX sponge appears to be a biocompatible orthopaedic implant and its use as a carrier for osteogenic proteins warrants further investigation.

Keywords

Non-union - osteoconduction - fracture - bone healing - hydrogel

• References

• 1 Seeherman HJ, Wozney J, Li R. Bone morphogenetic protein delivery systems. Spine 2002; 27: S16-S23.
• 2 Seeherman H. The influence of delivery vehicles and their properties on the repair of segmental defects and fractures with osteogenic factors. J Bone Joint Surg 2001; 83: S79-S81.
• 3 Saito N, Takaoka K. New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. Biomaterials 2003; 24: 2287-2293.
• 4 Burg KJ, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials 2000; 21: 2347-2359.
• 5 Liu Y, Ahmad S, Shu XZ. et al. Accelerated repair of cortical bone defects using a synthetic extracellular matrix to deliver human demineralized bone matrix. J Orthop Res 2006; 24: 1454-1462.
• 6 Ishihara A, Shields KM, Litsky AS. et al. Osteogenic gene regulation and relative acceleration of healing by adenoviral-mediated transfer of human BMP-2 or -6 in equine osteotomy and ostectomy models. J Orthop Res 2008; 26: 764-771.
• 7 Perrier M, Lu Y, Nemke B. et al. Acceleration of second and fourth metatarsal fracture healing with recombinant human bone morphogenetic protein-2/calcium phosphate cement in horses. Vet Surg 2008; 37: 648-655.
• 8 Mann BK, Gobin AS, Tsai AT. et al. 2001; Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: Synthetic ECM analogs for tissue engineering. Biomaterials 22: 3045-3051.
• 9 Liu Y, Shu XZ, Prestwich GD. Reduced postoperative intra-abdominal adhesions using carbylan-SX, a semisynthetic glycosaminoglycan hydrogel. Fertil Steril 2007; 87: 940-948.
• 10 Shu XZ, Ghosh K, Liu Y. et al. Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res Part A 2004; 68: 365-375.
• 11 Ghosh K, Ren XD, Shu XZ. et al. Fibronectin functional domains coupled to hyaluronan stimulate adult human dermal fibroblast responses critical for wound healing. Tissue Engineering 2006; 12: 601-613.
• 12 Shu XZ, Liu Y, Palumbo F. et al. Disulfide-crosslinked hyaluronan-gelatin hydrogel films: A covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials 2003; 24: 3825-3834.
• 13 Holmes RE. Bone regeneration within a coralline hydroxyapatite implant. Plastic Reconstr Surg 1979; 63: 626-633.
• 14 Kawcak C, Trotter G, Powers B. et al. Comparison of bone healing by demineralized bone matrix and autogenous cancellous bone in horses. Vet Surg 2000; 29: 218-226.